BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 11589274)

  • 1. Synthesis, analytical characterization and use of octakis(2,3-di-O-methyl-6-O-sulfo)-gamma-cyclodextrin, a novel, single-isomer, chiral resolving agent in low-pH background electrolytes.
    Busby MB; Lim P; Vigh G
    Electrophoresis; 2003 Jan; 24(3):351-62. PubMed ID: 12569527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, analytical characterization and initial capillary electrophoretic use in acidic background electrolytes of a new, single-isomer chiral resolving agent: hexakis(2,3-di-O-acetyl-6-O-sulfo)-alpha-cyclodextrin.
    Li S; Vigh G
    Electrophoresis; 2003 Aug; 24(15):2487-98. PubMed ID: 12900860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonaqueous capillary electrophoretic separation of basic enantiomers using octakis(2,3-O-dimethyl-6-O-sulfo)-gamma-cyclodextrin, a new, single-isomer chiral resolving agent.
    Busby MB; Maldonado O; Vigh G
    Electrophoresis; 2002 Feb; 23(3):456-61. PubMed ID: 11870748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative enantioseparations with native beta-cyclodextrin and heptakis-(2-O-methyl- 3,6-di-O-sulfo)-beta-cyclodextrin in capillary electrophoresis.
    Chankvetadze B; Burjanadze N; Maynard DM; Bergander K; Bergenthal D; Blaschke G
    Electrophoresis; 2002 Sep; 23(17):3027-34. PubMed ID: 12207312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, analytical characterization and initial capillary electrophoretic use in an acidic background electrolyte of a new, single-isomer chiral resolving agent: heptakis(2-O-sulfo-3-O-methyl-6-O-acetyl)-β-cyclodextrin.
    Tutu E; Vigh G
    Electrophoresis; 2011 Oct; 32(19):2655-62. PubMed ID: 21983817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heptakis(2-O-methyl-3,6-di-O-sulfo)-beta-cyclodextrin: a single isomer, 14-sulfated beta-cyclodextrin for use as a chiral resolving agent in capillary electrophoresis.
    Maynard DK; Vigh G
    Electrophoresis; 2001 Sep; 22(15):3152-62. PubMed ID: 11589274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of derivatized cyclodextrins as chiral selectors for the separation of enantiomers by gas chromatography.
    Schurig V
    Ann Pharm Fr; 2010 Mar; 68(2):82-98. PubMed ID: 20434597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capillary electrophoretic separations of enantiomers using cyclodextrin-containing background electrolytes.
    Vigh G; Sokolowski AD
    Electrophoresis; 1997 Nov; 18(12-13):2305-10. PubMed ID: 9456045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Separation of drug enantiomers by capillary electrophoresis in the presence of neutral cyclodextrins.
    Koppenhoefer B; Zhu X; Jakob A; Wuerthner S; Lin B
    J Chromatogr A; 2000 Apr; 875(1-2):135-61. PubMed ID: 10839142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enantiomeric separations of drugs using mixtures of charged and neutral cyclodextrins.
    Fillet M; Hubert P; Crommen J
    J Chromatogr A; 2000 Apr; 875(1-2):123-34. PubMed ID: 10839141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anionic cyclodextrins as versatile hosts for pharmaceutical nanotechnology: Synthesis, drug delivery, enantioselectivity, contrast agents for MRI.
    Mavridis IM; Yannakopoulou K
    Int J Pharm; 2015 Aug; 492(1-2):275-90. PubMed ID: 26168706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chiral separations: a review of current topics and trends.
    Ward TJ; Ward KD
    Anal Chem; 2012 Jan; 84(2):626-35. PubMed ID: 22066781
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.